This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1551 entries already.
Exeliom Biosciences, a French company focused on the microbiome-immunomodulation axis to develop next-generation immunotherapies, has announced the closing of its 24m (US$26m) Series A financing to advance the clinical development […]
It is just announced that it will soon be possible to taste farmed meat and seafood in the Netherlands under controlled conditions. The Dutch government, in collaboration with cultured meat […]
A long-awaited draft regulation from the EU Commission’s DG Sante to deregulate the authorisation, risk assessment and labelling of a whole range of new genetically modified organisms (GMOs) has been […]
Dutch venture builder NLC has announced a 20m first close for its new Health Impact Fund, from which it will invest in 40 startups, both new investments and follow-on. It’s […]
Carthera, a Sorbonne spin-off and developer of an innovative ultrasound-based medical device for the treatment of a wide range of brain disorders, today announced the successful completion of its 37.5m […]
Donaldson Company, Inc. (NYSE: DCI), a heritage provider of innovative filtration products and solutions, announced the acquisition of Univercells Technologies (Belgium), a global provider of innovative biomanufacturing solutions for cell […]
French AI-powered radiography diagnostics specialist Gleamer SAS has raises 27m in Series B round to expand its portfolio and accelerate its expansion.
Multi-omics diagnostics specialist Centogene NV has received 30m to form a joint venture with PIF-owned pharmaceutical company Lifera in Saudi-Arabia.
French cell and gene therapy manufacturing specialist Astraveus SAS had raises 16.5m in seed money to advance its automated, microfluidic Cell and Gene Therapy manufacturing platform.